Part II of our DEA cannabis rescheduling series features expert witnesses Dr. Philip Drum, Dr. Ken Finn, and Dr. Karen Randall, who expose the medical and public‑health dangers of moving marijuana to Schedule III. Topics include: • In‑utero cannabis exposure and fetal brain damage • Autism risk linked to parental cannabis use • Pediatric psychosis and hyperemesis • THC analogs like THCP sold to minors • Cancer trends in legalized regions • DEA misrepresentation of expert testimony • Why cannabis has no FDA‑approved medical use • How listeners can take action